Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | LRAT | O95237 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GJA1 | P17302 | 1/20 | 0.32 |
| ▸ | GJB2 | P29033 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19860207 | 0.82 | L3MBTL1 (0.36) | L3MBTL1MAPTTSHRHSD17B10MEN1 | |
| SCHEMBL22652633 | 0.77 | L3MBTL1 (0.33) | L3MBTL1MAPT | |
| Glucosamine SCHEMBL3802633 | 0.77 | PYGB (0.42) | L3MBTL1MAPTTSHRHSD17B10LMNA | |
| Glucosamine SCHEMBL28095460 | 0.77 | LGALS1 (0.42) | LMNAKDM4EALOX15 | |
| Glucosamine SCHEMBL29993892 | 0.77 | LGALS1 (0.42) | LMNAKDM4EALOX15 | |
| Glucosamine SCHEMBL24336697 | 0.76 | LGALS1 (0.45) | TSHRHSD17B10LMNAKDM4EALOX15 | |
| Glucosamine SCHEMBL21240813 | 0.76 | LGALS1 (0.45) | TSHRHSD17B10LMNAKDM4EALOX15 | |
| Glucosamine SCHEMBL13985995 | 0.76 | LGALS1 (0.45) | TSHRHSD17B10LMNAKDM4EALOX15 | |
| Glucosamine SCHEMBL22137006 | 0.76 | LGALS1 (0.45) | TSHRHSD17B10LMNAKDM4EALOX15 | |
| Glucosamine SCHEMBL22748633 | 0.76 | LGALS1 (0.45) | TSHRHSD17B10LMNAKDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11207343-B2 | Compositions and therapeutic methods | AYUVIS RESEARCH, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-10624984-B2 | Aptamer-modified polymeric materials for the binding of factors in a wound environment | KCI LICENSING, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| US-20200101103-A1 | REINFORCEMENT OF MUCUS BARRIER PROPERTIES | Cirqle Biomedical Contraception Ivs (DK) | 2020-04-02 | — | — | US | disclosed |
| US-20180042825-A1 | MICROCAPSULE COMPOSITIONS WITH HIGH PERFORMANCE | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-02-15 | — | — | US | disclosed |
| US-20170281667-A1 | NOVEL COMPOSITIONS AND THERAPEUTIC METHODS | AYUVIS RESEARCH, INC. | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11207343-B2 | Compositions and therapeutic methods | RB1, TNF, FLT1 | L3MBTL1 3218/4885MAPT 859/4885TSHR 2174/4885 |
| US-20180042825-A1 | MICROCAPSULE COMPOSITIONS WITH HIGH PERFORMANCE | UMPS, AUP1, PFAS | L3MBTL1 3667/4885MAPT 1192/4885TSHR 4241/4885 |
| US-20170281667-A1 | NOVEL COMPOSITIONS AND THERAPEUTIC METHODS | RB1, CD47, FLT1 | L3MBTL1 3066/4885MAPT 984/4885TSHR 2494/4885 |
| US-10624984-B2 | Aptamer-modified polymeric materials for the binding of factors in a wound environment | SDF4, PCLAF, CCL2 | L3MBTL1 1079/4885MAPT 4360/4885TSHR 3192/4885 |
| US-20200101103-A1 | REINFORCEMENT OF MUCUS BARRIER PROPERTIES | MUC1, FUT5, FUT8 | L3MBTL1 4469/4885MAPT 3691/4885TSHR 2005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.